logo
welcome
The Motley Fool

The Motley Fool

Prediction: These 2 Unstoppable Pharma Stocks Will Continue to Soar Through 2025 and Beyond

The Motley Fool
Summary
Nutrition label

78% Informative

Novo Nordisk and Eli Lilly are just getting started on their monster growth spree.

There's little indication that either company is about to slow down significantly, even in the face of a couple of headwinds.

The revenue impact of the expanded set of indications that both companies are working to explore hasn't even started yet.

Both are generating so much free cash flow that their coffers will be difficult to empty.

The 10 stocks that made the cut could produce monster returns in the coming years .

Consider when Nvidia made this list on April 15, 2005 ... if you invested $ 1,000 at the time of our recommendation, you’d have $ 763,374 ! The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002 .

VR Score

72

Informative language

68

Neutral language

32

Article tone

semi-formal

Language

English

Language complexity

54

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

medium-lived

External references

8

https://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&impression=ee067df2-eb66-4bb9-9647-79e2a505e762&url=https%3A%2F%2Fwww.fool.com%2Fmms%2Fmark%2Fe-foolcom-sa-bbn-dyn%3Faid%3D8867%26source%3Disaeditxt0010895%26ftm_cam%3Dsa-bbn-evergreen%26ftm_pit%3D13885%26ftm_veh%3Darticle_pitch_feed_yahoo%26company%3DEli%2520Lilly&utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=19dcf49e-4526-4dbf-a657-4afe65c43b8bhttps://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&impression=ee067df2-eb66-4bb9-9647-79e2a505e762&url=https%3A%2F%2Fwww.fool.com%2Fmms%2Fmark%2Fe-foolcom-sa-bbn-dyn%3Faid%3D8867%26amp%253Bsource%3Disaeditxt0010895%26ftm_cam%3Dsa-bbn-evergreen%26ftm_veh%3Darticle_pitch_feed_yahoo%26ftm_pit%3D13885&utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=19dcf49e-4526-4dbf-a657-4afe65c43b8bhttps://www.fool.com/investing/how-to-invest/what-to-invest-in/research-and-development/?utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=19dcf49e-4526-4dbf-a657-4afe65c43b8bhttps://www.fool.com/legal/fool-disclosure-policy/https://www.fool.com/investing/2024/08/19/prediction-these-2-unstoppable-pharma-stocks-will/?utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=19dcf49e-4526-4dbf-a657-4afe65c43b8bhttps://ycharts.com/companies/NVO/chart/https://www.fool.com/author/20287/https://www.fool.com/terms/f/free-cash-flow/?utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=19dcf49e-4526-4dbf-a657-4afe65c43b8b

Affiliate links

no affiliate links